Get
Noticed
HERE

Ask Pharma Compass

Free Demo Request

Global Pharmaceutical Intelligence

Smarter Sourcing, Faster Drug Launches, Quicker Business Leads, Killer Sales

    NEWS & ALERTS

    TOP 10 NEWS OF THE DAY

    NEWS LIBRARY

    Recent Approvals

    Compliance Alerts

    MARKET PLACE

    ENQUIRIES FOR APIs

    Post an enquiry PharmaCompass.com

    An Algerian pharmaceutical company, approved by the Ministry of Health for packaging and compress granules 'Oral form' ( non-antibiotic tablets and capsules ), is looking for suppliers of Valproic Acid and Sodium Valproate APIs (20kg and 10kg) for the first exhibit batches. Following the intial purchase order, the requirements are forecasted to be 527kg and 264kg for the first year & 3159kg and 1580kg for the second year, and 5267kg and 2633kg for the third year.

    Comments

    A trading company, present in global chemicals market since 1975, is searching for the suppliers/manufacturers of Ceftaroline Fosamil API 50 kg in Italy.

    Comments

    A company specialized in oral dispersible strips, is searching for suppliers/manufacturers of Dydrogesterone API for export to Switzerland. The anticipated quantity required is 5,200 kg.

    Comments

    ENQUIRIES FOR FINISHED FORMULATIONS

    Pharma Royal Company is searching for Enzalutamide 40 mg Capsules (Quantity-2520) for distribution in the Kurdistan region of Iraq.

    Comments

    David Health Vietnam, a distributor having a strong network with the obstetrics and gynecology association, and doctors across Vietnam is looking for Rx Prenatal Multivitamins. The distributor also needs master distribution right requirements for Vietnam.

    Comments

    A leading supplier of raw materials, active ingredients, excipients and packaging material for the pharmaceutical, veterinary and agrochemical industries is searching for suppliers of Adalimumab 40 mg/0.8 ml - 50 mg/ml Inj. solution 6000 vials, Infliximab 100 mg 4000 vials, Abatacept 125 mg/ml (4 vials/box) 4000 Boxes, Abatacept 250 mg/ml (4 vials/box), Tocilizumab 200 mg/10 ml 4000 vials, Tocilizumab 80 mg/4 ml 4000 vials, Certolizumab 200 mg/ml 3000 vials, Dasatinib 70 MG (7 tabs/box) 4000 boxes, Imatinib 100 mg (7 tabs/box) 4000 boxes and Imatinib 400 mg (7 tabs/box) 4000 boxes with GMP and dossier support from regulated markets for commercialization in Colombia.

    Comments

    FEATURED COMPANIES

    PARTIAL LIST OF PARTNER COMPANIES

    • Alchem International Private Ltd
    • Pfizer Inc
    • Biophore India Pharmaceuticals Pvt. Ltd
    • Isochem SA
    • Inke S.A.
    • Shodhana Laboratories Ltd
    • Bioindustria L.I.M. Spa
    • Mehta API Pvt. Ltd
    • Angelini Pharmaceuticals ACRAF
    • Cayman Pharma s.r.o.
    • Menadiona, S.L.
    • Chemwerth Inc
    • Farmak A.S.
    • Bloomage Freda Biopharm Co.,Ltd.
    • BIOTIKA a.s.
    • Ethypharm
    • Minakem SAS
    • JGL HR
    • A3P

    BLOG & ANALYSIS

    RADIO BLOG

    2016 — A year of data integrity issues and pharma non-compliances

    2016 — A year of data integrity issues and pharma non-compliances

    Data integrity was a hot topic of discussion in the pharmaceutical industry throughout 2016. Largely...

    Radio Compass

    PharmaCompass.com

    Trump’s comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion

    Trump’s comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion

    The New Year began with the JP Morgan Healthcare Conference— the drug industry’s annual ...

    Radio Compass

    PharmaCompass.com

    Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend

    Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend

    In less than three weeks, Donald Trump will assume office as the President of the United States. He ...

    Radio Compass

    PharmaCompass.com

    RADIO DATA

    2016 Recap of FDA Warning Letters, Import Alerts & EU Non-Compliances

    2016 Recap of FDA Warning Letters, Import Alerts & EU Non-Compliances

    Medicare Part D National Prescriber Summary Report, Calendar Year 2014

    Medicare Part D National Prescriber Summary Report, Calendar Year 2014

    Pharmaceutical Products for which parts of BE Studies were performed at Micro Therapeutic Research, India

    Pharmaceutical Products for which parts of BE Studies were performed at Micro Therapeutic Research, India

    MARKET INTELLIGENCE

    FEATURES OF MARKET INTELLIGENCE REPORTS

    EXAMPLE REPORTS

    PHARMA EVENTS & MEDIA COVERAGE

    PHARMA EVENTS

    Pharmapack Europe

    February 1 - 2, 2017

    Organizer: Pharmapack

    Paris - France

    A3P Barrier Technology

    March 14 - 15, 2017

    Organizer: A3P

    Pau, France

    ONE DAY A LABO - STERILIZATION

    March 23, 2017

    Organizer: A3P

    Clermont-Ferrand, France

    MEDIA COVERAGE OF PHARMACOMPASS

    PharmaCompass on Times Square in New York